Influence of endogenous DNA repair systems on PSMA-radioligand therapy in advanced prostate carcinoma

Dr. Particia Grabowski / Charité - Universitätsmedizin Berlin

Establishment of Teaching Modules for the ICPO Academy

Prof. Dr. Vikas Prasad / Universitätsklinikum Ulm

New SST2R-antagonists in the diagnosis of neuroendocrine tumors with PET/CT

Univ.-Prof. Dr. Frank Rösch / Johannes Gutenberg-Universität Mainz &
Dr. Theodosia Maina-Nock/National Center for Scientific Research Demokritos, Athens, Institute of Nuclear and Radiological Sciences, Energy, Technology and Safety

Novel drug delivery systems for improved therapy of Pca

Univ.-Prof. Dr. Frank Rösch / Johannes Gutenberg-Universität Mainz

High-dose Botulinum Toxin combined with transdermal scopolamin to prevent salivary gland destruction by PSMA-radioligand therapy for metastatic prostate cancer

Prof. Dr. Richard Baum/Curanosticum Wiesbaden-Frankfurt/Prof. Jörg Müller, FA für Neurologie und Ärztlicher Direktor Vivantes Klinikum Spandau